Brought to you by 
STAT-Diagnostica raises €17mm in Series B round
31 May 2013
Executive Summary
Kurma Life Sciences Partners has led a €17mm ($22.1mm) Series B financing for Spanish point-of-care testing company STAT-Diagnostica & Innovation SL. Other first-time investors Idinvest, Boehringer Ingelheim Venture Fund, and Caixa Capital Risc (the venture capital arm of the Spanish savings bank la Caixa) were joined by existing backers Ysios Capital Partners and Axis Participaciones Empresariales. Post-closing, Ysios becomes the start-up’s largest shareholder.
Deal Industry
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
STAT-Diagnostica raises €17mm in Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice